Login Register Cart 0
Generic placeholder image

Current Women`s Health Reviews

Editor-in-Chief

ISSN (Print): 1573-4048
ISSN (Online): 1875-6581

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Comparative Investigation of Color Doppler Ultrasonography Parameters of the Uterine Artery in Patients with Post-molar GTN and Patients Recovered from Molar Pregnancy and its Role in Predicting the Probability of Occurrence

Author(s): Malihe Hasanzadeh, Najmeh Jahani*, Sara Mirzaeian, Maryam Esmaeilpour and Marjaneh Farazestanian

Volume 20, Issue 3, 2024

Published on: 22 June, 2023

Article ID: e170523217009 Pages: 5

DOI: 10.2174/1573404820666230517121653

Price: $65

Abstract

Objectives: Hydatiform mole can progress to gestational trophoblastic neoplasia (GTN), and we are looking for non-invasive methods to predict it. Old age, higher serum BHCG levels, and expression of genes, such as VEGF-EG, HIF-1α, and TGF-ß are known as predictive factors. We performed this study to evaluate the role of bilateral uterine artery doppler ultrasound in predicting postmolar- GTN.

Methods: In this prospective cohort study, 42 patients with complete molar pregnancy were examined. Inclusion criteria confirmed molar pregnancy by histopathological examination. Exclusion criteria were patients more than 40 years old, patients with completed family childbearing planning, and diagnosis of GTN during the routine histopathological study. Before molar evacuation and four weeks later, bilateral uterine artery doppler sonography to determine the PI, RI, and PSV was performed. Serum BHCG levels were also measured before molar evacuation and weekly after evacuation until it exhibited spontaneous remission or developed GTN.

Results: About 36 patients were cured, and six others developed post-molar GTN. The bilateral uterine artery doppler sonography between the two groups showed a lower UA RI in the post-molar-GTN group before evacuation (P=0.048). Data demonstrated significant increases in Right.UA.RI (P=0/008), Left.UA.PI (P=0/037), and Right.UA.PSV (P=0/024) in the spontaneous remission group during 28 days follow-up period. There were no significant differences in these parameters in the GTN group throughout the time of follow-up.

Conclusion: It seems that Doppler ultrasound plays a role in predicting GTN following uterine evacuation. A lower resistance in the uterine artery before evacuation and the remaining uterine artery blood flow constant after evacuation is associated with the development of post-molar- GTN.

Graphical Abstract

[1]
Donald, P. Gestational Trophoblastic Disease. Abeloff's Clinic. Oncol. 2020, 2020, 87.
[http://dx.doi.org/10.1016/B978-0-323-47674-4.00087-6]
[2]
Amr, H. Doppler ultrasound in post-molar gestational trophoblastic neoplasia. Open J. Obstetrics Gynecol., 2020, 10, 583-598.
[3]
Jiang, F.; Wan, X.; Xu, T.; Feng, F.; Ren, T.; Yang, J.; Zhao, J.; Yang, T.; Xiang, Y. Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: A ten-year review of 1420 patients. Gynecol. Oncol., 2018, 149(3), 539-544.
[http://dx.doi.org/10.1016/j.ygyno.2018.04.001] [PMID: 29653688]
[4]
Hoamee, F Comparison of serum BHCG curvilinear regression between molar pregnancy and trophobalstic tumor. J. Hums., 2010, 18(1), 62-66.
[5]
Hasanzadeh, M.; Samadi, F.; Mousavi, L.; Homaee, F. Evaluation of the relation between treatment results and predictive factors in metastatic and high risk gestational trophoblastic neoplasia. Middle East J. Cancer, 2019, 10(3), 214-220.
[6]
Jonathan, S.B. Berek & Novak's Gynecology, (16th Edi. ) 2019 Wolters Kluwer press, p. 1232.
[7]
Flavia, Tarabini Castellani Asmar; Braga-Neto, Antonio Rodrigues Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study. Clinics, 2017, 72(5), 284-288.
[8]
Sita-Lumsden, A.; Short, D.; Lindsay, I.; Sebire, N.J.; Adjogatse, D.; Seckl, M.J.; Savage, P.M. Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009. Br. J. Cancer, 2012, 107(11), 1810-1814.
[http://dx.doi.org/10.1038/bjc.2012.462] [PMID: 23059744]
[9]
Berkowitz, R.S.; Goldstein, D.P. Molar pregnancy. N. Engl. J. Med., 2009, 360(16), 1639-1645.
[http://dx.doi.org/10.1056/NEJMcp0900696] [PMID: 19369669]
[10]
Cavoretto, P.; Gentile, C.; MangilI, G.; Garavaglia, E.; Valsecchi, L.; Spagnolo, D.; Montoli, S.; Candiani, M. Transvaginal ultrasound predicts delayed response to chemotherapy and drug resistance in Stage I low-risk trophoblastic neoplasia. Ultrasound Obstet. Gynecol., 2012, 40(1), 99-105.
[http://dx.doi.org/10.1002/uog.11097] [PMID: 22262502]
[11]
Nadeem, R. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)Gestational Trophoblastic Neoplasia. Version 2.2020; , 2020. Available from: https://dignicap.com/nccn-and-clinical-guidelines/?campaignid=12889960752&adgroupid=12449 7967667&feeditemid=&cikw=Nccn%20guidelines&MatchType=b&device=c&ci_source=paid&loc_physical_ms=9077134&loc_interest_ms=&network=g&devicemodel=&adposition=&gclid=Cj0KCQjww4-hBhCtARIsAC9gR3YFPNiz4GdU5WGVA9WXY DOWnu-o03w2Rz_cJQ2yXRAsCz5x0R3rcGoaAhYgEALw_wcB
[12]
Oguz, S.; Sargin, A.; Aytan, H.; Kelekci, S.; Dumanli, H. Doppler study of myometrium in invasive gestational trophoblastic disease. Int. J. Gynecol. Cancer, 2004, 14(5), 972-979.
[http://dx.doi.org/10.1111/j.1048-891X.2004.14537.x] [PMID: 15361211]
[13]
Agarwal, R.; Harding, V.; Short, D.; Fisher, R.A.; Sebire, N.J.; Harvey, R.; Patel, D.; Savage, P.M.; Lim, A.K.P.; Seckl, M.J. Uterine artery pulsatility index: A predictor of methotrexate resistance in gestational trophoblastic neoplasia. Br. J. Cancer, 2012, 106(6), 1089-1094.
[http://dx.doi.org/10.1038/bjc.2012.65] [PMID: 22374461]
[14]
Yalcin, OT.; Ozalp, SS.; Tanir, HM. Assessment of gestational trophoblastic disease by Doppler ultrasonography. Eur. J. Obstet. Gynecol. Reprod. Biol., 2002, 103(1), 83-87.
[http://dx.doi.org/10.1016/S0301-2115(02)00026-X]
[15]
Malek, M; Moradi, B; Mousavi, AS; Ahmadinejad, N; Kazemi, MA; Gity, M Complementary role of ultrasound in management of gestational trophoblasticdisease. Iran J. Radiol., 2015, 12(2), 13955.
[16]
Chan, F.Y.; Pun, T.C.; Chau, M.T.; Lam, C.; Ngan, H.Y.S.; Wong, R.L.C. The role of Doppler sonography in assessment of malignant trophoblastic disease. Eur. J. Obstet. Gynecol. Reprod. Biol., 1996, 68(1-2), 123-128.
[http://dx.doi.org/10.1016/0301-2115(96)02480-3] [PMID: 8886694]
[17]
Yvonne, M.; Yalck, K.E; Leon, F.A.G.; Dandis, R.; Inthout, J.; Trommel, N.E.; Petronella, B.O; Chris, M.G.; Thomas, F. Early prediction of post-molar gestational trophoblastic neoplasia and resistance to methotrexate, based on a single serum human chorionic gonadotropin measurement. Gynecol. Oncol., 2021, 163, 531-537.
[18]
Lurain, J.R. Gestational trophoblastic disease I: Epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am. J. Obstet. Gynecol., 2010, 203(6), 531-539.
[http://dx.doi.org/10.1016/j.ajog.2010.06.073] [PMID: 20728069]
[19]
Ayhan, A.; Tuncer, Z.S.; Halilzade, H.; Küçükali, T. Predictors of persistent disease in women with complete hydatidiform mole. J. Reprod. Med., 1996, 41(8), 591-594.
[PMID: 8866387]
[20]
Gungor, T.; Ekin, M.; Dumanli, H.; Gokmen, O. Color Doppler ultrasonography in the earlier differentiation of benign molehydatidiforms from malignant gestational trophoblastic disease. Acta Obstet. Gynecol. Scand., 1998, 77(8), 860-862.
[http://dx.doi.org/10.1080/j.1600] [PMID: 9776602]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy